title: Phenylalanine 30 plays an important role in receptor binding of verotoxin-1.
abstract: The homopentameric B subunit of verotoxin 1 (VT1) binds to the glycosphingolipid receptor globotriaosylceramide (Gb3). We produced mutants with alanine substitutions for residues found near the cleft between adjacent subunits. Substitution of alanine for phenylalanine 30 (Phe-30) resulted in a fourfold reduction in B subunit binding affinity for Gb3 and a 10-fold reduction in receptor density in a solid-phase binding assay. The interaction of wild-type and mutant B subunits with Pk trisaccharide in solution was examined by titration microcalorimetry. The carbohydrate binding of the mutant was markedly impaired compared with that of the wild type and was too weak to allow calculation of a binding constant. These results demonstrate that the mutation significantly impaired the carbohydrate-binding function of the B subunit. To ensure that the mutation had not caused a significant change in structure, the mutant B subunit was crystallized and its structure was determined by X-ray diffraction. Difference Fourier analysis showed that its structure was identical to that of the wild type, except for the substitution of alanine for Phe-30. The mutation was also produced in the VT1 operon, and mutant holotoxin was purified to homogeneity. The cytotoxicity of the mutant holotoxin was reduced by a factor of 10(5) compared to that of the wild type in the Vero cell cytotoxicity assay. The results suggest that the aromatic ring of Phe-30 plays a major role in binding of the B subunit to the Galalpha1-4Galbeta1-4Glc trisaccharide portion of Gb3. Examination of the VT1 B crystal structure suggests two potential carbohydrate-binding sites which lie on either side of Phe-30.
authors.affiliation: Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
authors.forename: C
authors.initials: C
authors.lastname: Clark
authors.forename: D
authors.initials: D
authors.lastname: Bast
authors.forename: A M
authors.initials: AM
authors.lastname: Sharp
authors.forename: P M
authors.initials: PM
authors.lastname: St Hilaire
authors.forename: R
authors.initials: R
authors.lastname: Agha
authors.forename: P E
authors.initials: PE
authors.lastname: Stein
authors.forename: E J
authors.initials: EJ
authors.lastname: Toone
authors.forename: R J
authors.initials: RJ
authors.lastname: Read
authors.forename: J L
authors.initials: JL
authors.lastname: Brunton
mesh_terms: D000595:Amino Acid Sequence; D001427:Bacterial Toxins / Q000737:chemistry / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D002151:Calorimetry; D018360:Crystallography, X-Ray; D004926:Escherichia coli / Q000737:chemistry / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D005583:Fourier Analysis; D006017:Glycolipids / Q000378:metabolism*; D008969:Molecular Sequence Data; D009154:Mutation; D010649:Phenylalanine; D011485:Protein Binding; D011487:Protein Conformation; D011956:Receptors, Cell Surface / Q000378:metabolism*; D022622:Shiga Toxin 1; D014281:Trihexosylceramides / Q000378:metabolism*
chemical_list: D001427:Bacterial Toxins; D006017:Glycolipids; D011956:Receptors, Cell Surface; D022622:Shiga Toxin 1; C068556:Shiga-like toxin receptor; D014281:Trihexosylceramides; D010649:Phenylalanine; C018549:globotriaosylceramide